Qualitative Findings: Family Building Counseling for SCD

This post summarizes the PLOS One qualitative study on sickle cell family building counseling and reframes the findings for teams doing qualitative research and care improvement. The primary keyword is sickle cell family building counseling and the target audience is clinical researchers, reproductive health teams, and qualitative analysts who need reproducible thematic evidence and actionable next steps. According to the PLOS One study published on August 24, 2026, adults with sickle cell disease described gaps in counseling, low awareness of assisted reproductive technology, and financial barriers that limited consideration of IVF and PGT.

Key Takeaways

According to the PLOS One study published August 24, 2026, adults with sickle cell disease reported limited fertility counseling, poor understanding of pregnancy risks, and cost as a key barrier to assisted reproductive technology (PLOS One).

11 interviews were completed between February 2024 and September 2024 with 9 women and 2 men, mean age 30.6 years, according to the PLOS One study published August 24, 2026.
About 100, 000 Americans live with sickle cell disease, and the PLOS One paper cites life expectancy rising to 54 years in 2019, which increases reproductive planning needs (PLOS One, August 24, 2026).
Participants in the PLOS One study said they wanted "earlier and frequent discussions" with providers, and one participant summarized a clinical gap: "I know that it [hydroxyurea] is something I couldn’t be on while pregnant…" (participant quoted in PLOS One, August 24, 2026).
The PLOS One study reported that financial cost and insurance coverage prevented serious consideration of IVF/PGT, and the paper references a 2023 cost-effectiveness analysis showing IVF with PGT could yield incremental savings of over $130, 000 compared to lifetime standard care (PLOS One, August 24, 2026).

What happened and how the study was done

The PLOS One study conducted 11 semi-structured video interviews of adults with sickle cell disease between February 2024 and September 2024 to explore experiences of family building counseling and perceptions of reproductive technology (PLOS One, published August 24, 2026).

According to the PLOS One methods section, participants were recruited at a single Midwestern tertiary care sickle cell center, interviews averaged 34 minutes (SD 12 minutes), and transcripts were thematically analyzed using inductive coding and the social ecological model (PLOS One, August 24, 2026).

According to the PLOS One results, five saturated themes emerged: limited provider support for family building planning; lack of female participants' understanding of pregnancy with SCD; uneven partner involvement in planning; financial barriers to ART; and desire for earlier and more frequent provider conversations (PLOS One, August 24, 2026).

Findings snapshot

Date	Metric	Value	Implication
August 24, 2026	Study publication	PLOS One	Primary qualitative evidence on SCD family building counseling
Feb–Sep 2024	Interviews completed	11 interviews (9 women, 2 men); mean age 30.6 years	Themes reached saturation for counseling experiences (PLOS One)
2019 (cited in study)	Life expectancy for people with SCD	54 years	More patients reach reproductive age, increasing counseling needs (PLOS One)
2023 (cited in study)	Economic analysis	IVF with PGT incremental savings > $130, 000 (2023 analysis)	Cost-effectiveness may contrast with individual cost barriers reported by participants (PLOS One)
2024 (recruitment)	Interview length	Average 34 minutes (SD 12 minutes)	Sufficient depth for thematic qualitative analysis (PLOS One)

Implications for researchers and clinicians

Clinicians and researchers should treat family building counseling as a routine, longitudinal part of sickle cell care because the PLOS One study found participants wanted earlier and repeated discussions (PLOS One, August 24, 2026).

According to PLOS One, educational materials and counseling should address both genetic transmission (partner testing) and fertility impacts of SCD and its therapies, because participants described limited understanding of fertility risks and hydroxyurea as a pregnancy-related medication concern (PLOS One, August 24, 2026).

According to the PLOS One study, program design must address structural barriers: participants cited cost and insurance limits for ART as deterrents, and the paper connects these barriers to documented racial and socioeconomic disparities in ART access (PLOS One, August 24, 2026).

For clinical teams: implement standardized questions about reproductive goals at transition visits and document partner testing status, as suggested by participant requests in PLOS One (August 24, 2026).
For researchers: include partner and family perspectives in future qualitative work because participants requested partner-directed resources and involvement (PLOS One, August 24, 2026).
For health systems: evaluate coverage and referral pathways for fertility preservation and ART, noting the PLOS One study’s finding that financial barriers prevented serious consideration of ART (PLOS One, August 24, 2026).

How Evidano helps bridge the research-to-care gap

What is Evidano and why it matters for this research

Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents.

Evidano can ingest interview transcripts, extract themes, quantify code frequencies, and produce cross-segment comparisons that speed reproducible synthesis of patient-identified needs like those reported in PLOS One (PLOS One, August 24, 2026).

Evidano’s thematic and cross-segment outputs map directly to actions clinicians and researchers need: identify which provider messages are missing, surface patient language to reuse in counseling, and prioritize structural barriers reported by participants.

Problem: small qualitative samples are hard to scale to policy

Solution: Evidano’s automated thematic synthesis turns coded transcripts into exportable evidence summaries and stakeholder-ready tables, which helps translate small-N studies like the PLOS One analysis into implementable recommendations.

Problem: manual transcription and PII redaction slow analysis

Solution: Evidano provides secure transcription with custom dictionaries and PII redaction so teams can process video interviews like those collected in Feb–Sep 2024 and focus on interpretation rather than cleanup; see Evidano features.

Problem: teams need to test counseling language and measure reach

Solution: Evidano supports mixed data ingestion (surveys, transcripts, documents) to quantify how often themes such as "cost barrier" or "lack of fertility counseling" appear across segments, enabling teams to measure change over time and by payer status.

FAQ: sickle cell family building counseling

What did the PLOS One study find about family building counseling for adults with sickle cell disease?

Answer: The PLOS One study found that adults with sickle cell disease reported limited counseling about fertility and family building and wanted earlier, frequent discussions with providers (PLOS One, August 24, 2026).

Supporting detail: The PLOS One study identified five themes from 11 interviews, including limited provider support, poor understanding of pregnancy with SCD, uneven partner involvement, financial barriers to ART, and a desire for more provider conversations (PLOS One, August 24, 2026).

How many people were interviewed in the PLOS One qualitative study and when were interviews conducted?

Answer: The PLOS One study completed 11 interviews with 9 women and 2 men conducted from February 2024 to September 2024 (PLOS One, August 24, 2026).

Supporting detail: Interviews averaged 34 minutes (SD 12 minutes) and participants were recruited at a single tertiary sickle cell center, as described in the PLOS One methods (August 24, 2026).

Did participants know about IVF and preimplantation genetic testing (PGT)?

Answer: Most participants were aware of IVF but few had heard of PGT prior to the interviews, and cost concerns limited serious consideration of ART (PLOS One, August 24, 2026).

Supporting detail: The PLOS One paper reports variable interest in PGT, with some participants concerned about ethical implications and others seeing it as a way to avoid having a child with SCD (PLOS One, August 24, 2026).

How can qualitative researchers reproduce or extend these findings efficiently?

Answer: Researchers can preregister interview guides, collect structured demographic metadata, and use AI-assisted coding to accelerate reproducible theme extraction, as recommended by the analytic approach in PLOS One (August 24, 2026).

Supporting detail: The PLOS One team used inductive coding, a codebook, and NVivo to reach saturation; AI tools can automate initial coding and frequency counts while preserving human-driven interpretation.

Conclusion & Next Steps

The PLOS One study published August 24, 2026, documents clear gaps in family building counseling for adults with sickle cell disease and identifies patient priorities for earlier, repeated, and partner-inclusive conversations (PLOS One).

Researchers and clinical teams should prioritize accessible education, partner testing workflows, and policy advocacy for insurance coverage of ART given the cost barriers described in the study (PLOS One, August 24, 2026).

Evidano helps teams turn interview transcripts into actionable evidence summaries and measurable program metrics; for product details see Evidano features.

If you want to accelerate qualitative synthesis and convert patient voices into implementable recommendations, Try Evidano for free.

Topics

sickle cell family building counseling
family building counseling SCD
qualitative analysis SCD family planning
ART perceptions sickle cell

Keep reading

Browse all articles